US2889337A - Isolation of furocoumarins - Google Patents

Isolation of furocoumarins Download PDF

Info

Publication number
US2889337A
US2889337A US598971A US59897156A US2889337A US 2889337 A US2889337 A US 2889337A US 598971 A US598971 A US 598971A US 59897156 A US59897156 A US 59897156A US 2889337 A US2889337 A US 2889337A
Authority
US
United States
Prior art keywords
solvent
fractions
compound
column
geranoxypsoralen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US598971A
Inventor
William L Stanley
Sadie H Vannier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US598971A priority Critical patent/US2889337A/en
Application granted granted Critical
Publication of US2889337A publication Critical patent/US2889337A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Definitions

  • This invention relates broadly to the production of coumarins and furocoumarins (psoralens) by isolation from natural sources, particularly from citrus oils, and by organic synthesis.
  • Particular objects of the invention include the provision of processes for isolating from citrus oils such compounds as: S-geranoxypsoralen; 7- methoxy-S-geranoxycoumarins; -(gamma,gamma dimethyl) allyloxypsoralen; 7-methoxy-5-(gamma,gammadimethyl) allyloxycoumarin; 8-geranoxypsoralen; 5,7-dimethoxycoumarin; and 5-rnethoxy-8-(2,3-dihydroxy-3- methylbutoxy)-psoralen.
  • Another object of the invention is the provision of the hitherto-unknown compound, S-geranoxypsoralen, in pure crystalline form free from other citrus oil components.
  • Another object of the invention is the provision of methods for converting the naturally occurring coumarins and furocoumarins into other derivatives, for example, conversion of S-geranoxypsoralen into S-methoxypsoralen. Further objects and advantages of the invention will be obvious from the following description.
  • the compound S-geranoxy psoralen is present in citrus oils, particularly lemon and lime oils.
  • This compound can be isolated from the oil by a process which involves primarily adsorption on an adsorbent material followed by elution with a suitable solvent. It has also been found that by this same isolation method, other coumarins and furocoumarins can be recovered.
  • the isolated 8-geranoxy-psoralen can be converted into 8-methoxypsoralen or other alkyl ethers as described below. Similar syntheses can be applied to the other compounds isolated from the citrus oil. It is to be emphasized that the presence of 8-geranoxypsoralen in citrus products was not known prior hereto.
  • the raw atent ice material for this purpose is usually an oil obtained by cold pressing the peels of lemons, limes, grapefruit, bitter oranges, bergamot, etc. Citrus oils obtained by other procedures which do not involve distillation can also be used. Where the citrus oil is purified by distillation, the distillation residue (undistilled material) contains the desired compounds and can be used as the starting material. In any event, the oil is first adsorbed on a finely divided adsorbent material such as silicic acid.
  • This material containing adsorbed oil is then eluted with a terepenophilic solvent such as hexane whereby the undesired terpene hydrocarbons originally present in the oil are selectively eluted from the adsorbent.
  • the adsorbent is then eluted with a liquid containing both a terpenophilic solvent, such as hexane, and an oxygenated organic solvent, such as ethyl acetate.
  • the eluate which contains the various ethereal components of the oil iscollected in separate fractions as it flows out of the adsorbent column. These fractions are subjected to analytical tests and those which are rich in a particular component are combined.
  • the combined material is then subjected to evaporation to remove at least part of the eluting solvent and the coumarin or furocoumarin is crystallized from the concentrated eluate.
  • EXAMPLE I A. Preparation of adsorbent column Powdered silicic acid was formed into a slurry with hexane and poured into a conventional chromatographic cylinder. Nitrogen gas under pressure was applied at the top of the column to force out excess hexane. There was formed a column of hexane-wetted silicic acid 3.5 inches in diameter and 10 inches long.
  • the first portion of the eluate contained the known compound S-geranoxy psoralen where R represents the geranyl radical:
  • the third portion of the eluate contained a compound giving an R; value of 0.57 and a purple color under ultra violet light.
  • the fourth portion of the eluate contained a compound giving an R; value of 0.5 and a blue color under ultra-violet light.
  • R represents the geranyl radical
  • the compound S-geranoxypsoralen has a melting point of 59-60" C.; it is insoluble in water, sparingly soluble in petroleum ether, moderately soluble in alcohol and ethyl ether, and quite soluble in ethyl acetate. Its ultra violet spectrum shows maxima at 217, 250, and 298 millimicrons, shoulders at 244 and 264 millimicrons, and minima at 232 and 277 millimicrons.
  • the crystalline compound was identified as 8-geranoxypsoralen based on the following observations: The compound gave a carbon and hydrogen analysis correct for C H O The compound exhibited typical lactone behavior and absence of free phenol hydroxyl groups by virtue of the effect of cold caustic (no shift in spectral peaks) and heating with caustic (marked shift of spectral peaks toward red) on its ultra violet spectra. Cleavage with weak acids indicated the presence of an allylic type ether group which was confirmed to be the geranyl other group by infra red spectral studies. Also the compound when cleaved with weak acid formed a phenol which on methylation or acetylation formed the known compounds S-methoxypsoralen, and 8-acetoxypsoralen, respectively.
  • the sixth portion of the eluate contained the known compound 5,7-dimethoxy coumarin, also known as limettin.
  • This compound in the described test gave an R, value of 0.25 and a blue color under ultra-violet light.
  • EXAMPLE III Another run was carried out as described in Example 1, parts A to D. In this instance, 190 g. of lime oil was adsorbed on a column of silicic acid 2.5 inches in diameter and 11 inches long. The terpenes were removed by eluting the column with 1,000 ml. hexane. The column was then eluted with 7,000 ml. of a solution of ethyl acetate in hexane, starting with a solution containing 5% ethyl acetate in hexane and increasing the proportion of ethyl acetate in each batch of about 500 ml. until the final concentration of ethyl acetate was 75%.
  • the column was then eluted with 400 ml. of 5% ethyl alcohol in ethyl acetate and finally with 500 ml. of ethyl alcohol in ethyl acetate. A total of 965 fractions were collected.
  • the total yield of 8-geranoxypsoralen was 0.16% by weight based on the amount of lime oil. 7
  • adsorption and elutions we usually prefer to conduct the adsorption and elutions on a column.
  • a cylinder is packed with a finely divided solid adsorbent.
  • various other adsorbents can be employed as for example, alumina, silica, magnesium oxide, magnesium hyf' droxide, aluminum hydroxide, bentonite, clays, diatomaceous earths, and so forth.
  • this column is first wetted with the terpenophilic solvent whereby to minimize isomerization of reactive compounds present in the citrus oil.
  • terpenophilic solvent as used herein means an organic solvent which has a greater afiinity for terpenes than the latter have afiinity for the adsorbent.
  • terpenophilic solvent we prefer to use hexane although many other materials within this class give good results, examples being benzene, carbon disulphide, carbon tetrachloride, and mixtures of hydrocarbons such as gasoline, petroleum naphtha, petroleum ether, and so forth.
  • the terpenophilic solvent should have a boiling point below C. to facilitate its removal by distillation from the separated terpenes.
  • the citrus oil is applied thereto.
  • vacuum By application of vacuum to the receiver"at-' tached to the bottom of the column the oil can be drawn into the adsorbent.
  • pressure can be applied at the top of the column to force the oil into the adsorbent.
  • the column is then ready for elution of the terpene constituents. This is accomplished by washing the column with hexane or other terpenophilic solvent as described above. In conducting this elution, it is preferable to pass the selected solvent through the adsorbent column while taking small samples of the efiluent liquidand subjecting them to chromatographic or other analytical tests. By this means, one can ascertain when the effluent contains the terpenes.
  • the terpene-containing efiluent can then be collected and saved for recovery of terpenes.
  • the point when the eflluent no longer contains terpenes can also be determined.
  • the collection of the solvent can be discontinued and the column is ready for elution of the coumarin and furocoumarin derivatives.
  • the total amount of terpenophilic solvent to be used will vary depending on the amount of adsorbent and amount of terpenes in the citrus oil. In any case by using the tests on the efiluent liquor, the
  • the terpenes may be recovered from the efiiuent solution by distillation. Vacuum distillation is preferred to minimize decomposition of the terpenes.
  • the column is eluted to remove the coumarins and furocoumarins.
  • This elution is conducted with ethyl acetate or other oxygenated organic solvent such as diethyl ether, dioxane, acetone, ethyl alcohol, normal or iso-propyl alcohol, any of the isomeric butyl alcohols, etc.
  • the elution is initially conducted with a solvent which contains both oxygenated organic solvent and terpenophilic solvent, for example, a solution of ethyl acetate in hexane. In this way the various oxygenated compounds adsorbed on the column are eluted more or less serially rather than in one batch containing all of them.
  • the solvent contains only the oxygenated organic solvent, for example, ethyl acetate, ethyl alcohol, or mixtures thereof.
  • the eluate flows from the column, it is collected in separate fractions, for example, by the use of an automatic fraction collector as is well known in the field of chromatography. These individual fractions are then subjected to chromatographic or other tests to ascertain the presence of the desired furocoumarin.
  • the fractions which contain this compound are then combined, subjected to evaporation to remove at least part of the solvent and allowed to stand, preferably with cooling, to allow the compound to crystallize out.
  • the other fractions may be likewise treated to isolate the various coumarins or furocoumarins originally present in the citrus oil.
  • the eluate fractions which contain two or more of the desired components can be re-treated to separate them. To this end the fractions are subjected to evaporation to remove solvent and the residue is adsorbed on a solid adsorbent material and eluted as previously described.
  • terpenes are removed from the citrus oil by elution of the adsorbed oil with hexane or similar terpenophilic solvent.
  • Other methods can be used to eliminate the terpenes, for example, application of distillation to remove the terpenes as a vapor and leave behind the essentially nonvolatile coumarins and furocoumarins. The distillation residue can then be processed as described to separate the individual components.
  • S-geranoxypsoralen can be readily converted into derivatives having photodynamic activity. Such synthesis is preferably accomplished in two stagesfirst by splitting the 8-geranoxypsoralen to form 8-hydroxypsoralen and then reacting the latter with an etherification agent. In the first stage the S-geranoxy compound is reacted with an ether hydrolyzing agent, for example, acetic acid, sulphuric acid, hydrochloric acid, hydroiodic acid or the like. Usually the hydrolysis is performed with glacial acetic acid which acts both as a solvent and as a hydrol ytic agent. To expedite hydrolysis a minor amount of strong acid such as sulphuric is added. to the reaction mixture.
  • an ether hydrolyzing agent for example, acetic acid, sulphuric acid, hydrochloric acid, hydroiodic acid or the like.
  • acetic acid for example, acetic acid, sulphuric acid, hydrochloric acid, hydroiodic acid or the like
  • the hydrolysis can be conducted at a temperature from about zero to 100 C. depending on the eflicacy of the hydrolysis agent selected.
  • the hydrolysis is conducted with the S-geranoxy compound dissolved in an inert solvent such as ethanol, benzene, acetone, etc, and the reaction is carried out at a temperature above the boiling point of the solvent, refluxing conditions may be employed to prevent loss of solvent.
  • an etherifying agent for example diazomethane, dimethyl sulphate, or methyl iodide where the aim is to prepare the 8-methoxy derivative.
  • etherification agents as for example diethyl sulphate, ethyl iodide, dipropyl sulphate, propyl iodide, diisopropyl sulphate, isopropyl iodide, di-butyl sulphate, butyl iodide, and so forth.
  • an alkaline agent such as potassium carbonate, sodium carbonate, potassium hydroxide, sodium hydroxide, lime, sodium ethylate, or the like is added to the reaction mixture to promote the etherification by reacting with the anion of the etherifying agent.
  • the etherification is preferably conducted under reflux in the presence of an inert solvent such as acetone, ethanol, dioxane, etc.
  • trans-etherification may be employed.
  • the 8 -geranoxy derivative may be refluxed with an excess of absolute methanol in the presenceof an acid catalyst such as hydrogen chloride, sulphuric acid, etcJto obtain a replacement of the geranyl radical with the methyl radical.
  • an acid catalyst such as hydrogen chloride, sulphuric acid, etcJto obtain a replacement of the geranyl radical with the methyl radical.
  • Typical examples of such syntheses are the conversion of S-geranoxypsoralen to S-methoxypsoralen; the conversion of 7-methoxy-5-geranoxy coumarin to 5,7-dirnethoxy coumarin; the conversion of 5-(gamma,gamma-dimethy1) allyloxypsoralen to 5- methoxypsoralen; the conversion of S-(gamma-gamma, dimethyl)-allyloxycoumarin to S-methoxycoumarin; and so forth.
  • EXAMPLE IV A. Cleavage of 8-geranoxyps0ralen Two hundred seventy-five mg. of 8-geranoxypsoralen was dissolved with mechanical stirring in 4 ml. glacial acetic acid. After 10 minutes, one drop of concentrated sulphuric acid was added to the solution. In 4 minutes thereafter a light tan precipitate began to form.
  • Stirring B Methylation of 8-hydr0xypsoralen
  • One hundred fifteen mg. of 8-hydroxypsoralen was dissolved in 10 ml. absolute methanol, an excess of diazomethane dissolved in ether was added and the mixture allowed to stand at room temperature with occasional stirring for 3 hours. The next day the reaction mixture was reduced in volume to 3 ml.
  • EXAMPLE V Methylation of 8-hydr0xypsoralen with methyl iodide (or sulphate)
  • EXAMPLE VI A. Clevage of S-germzoxypsoralen Four hundred and ninety milligrams of S-geranoxypsoralen was dissolved in 5 cc. glacial acetic acid.
  • a process for isolating coumarins and furocoumarins from a citrus oil which comprises adsorbing the citrus oil on a solid adsorbent material, eluting the adsorbent material with a liquid comprising an oxygenated organic solvent, collecting the resulting eluate in a series of fractions containing individual coumarins and furocoumarins, and individually recovering the coumarins and furocoumarins from the fractions.
  • a process for isolating a furocouman'n from a citrus oil which comprises adsorbing the citrus oil on a solid adsorbent material, eluting the adsorbing material with a liquid comprising an oxygenated organic solvent, collecting the resulting eluate in a series of fractions, separating the fractions containing the furocoumarin, and recovering the furocoumarin therefrom.
  • a process for isolating furocoumarins from a citrus oil which comprises adsorbing a citrus oil on a solid adsorbent material, extracting the adsorbent material with a terpenophilic solvent to remove terpene constituents, eluting the adsorbent material with a liquid comprising a terpenophilic solvent and an oxygenated organic solvent then with an oxygenated solvent alone, collecting the resulting eluate in a series of fractions containing individual furocoumarins, and individually recovering furocoumarins from the fractions.
  • furocoumarins include S-methoxy-S(2,3-dihydroxy-3-methyl butoxy)- psoralen.
  • a process for isolating S-geranoxypsoralen from citrus oil which comprises adsorbing the citrus oil on a solid adsorbent, extracting the adsorbent with hexane to remove terpene components, eluting the adsorbent with initially a liquid containing a minor proportion of ethyl acetate dissolved in hexane, then with a series of liquids containing increasing proportions of ethyl acetate to hexane, then with ethyl acetate alone, and finally with a liqud containing ethyl acetate and ethanol, collecting the eluate in a series of separate fractions, combining the fractions which contain S-geranoxypsoralen and recover- :ing the S-geranoxypsoralen therefrom.
  • a process for isolating S-geranoxypsoralen from citrus oil which comprises adsorbing the citrus oil on a :solid adsorbent, extracting the adsonbent with hexane to remove terpene components, eluting the adsorbent with initially a liquid containing a minor proportion of ethyl acetate dissolved in hexane, then with a series of liquids containing increasing proportions of ethyl acetate to l hexane, then with ethyl acetate alone, and finally with a liquid containing ethyl acetate and ethanol, collecting the eluate in a series of separate fractions, combining the fractions which contain 8-geranoxypsoralen and recovering the 8-geranoxypsoralen therefrom.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Fats And Perfumes (AREA)

Description

Unite ISOLATION OF FUROCOUMARINS No Drawing. Application July 19, 1956 Serial No. 598,971
13 Claims. ((31. 260-3431) (Granted under 'Iitle 35, U8. Code (1952), see. 266) A non-exclusive, irrevocable, royalty-free license in the invention herein described, throughout the world for all purposes of the United States Government, with the power to grant sublicenses for such purposes is hereby granted to the Government of the United States of America.
This invention relates broadly to the production of coumarins and furocoumarins (psoralens) by isolation from natural sources, particularly from citrus oils, and by organic synthesis. Particular objects of the invention include the provision of processes for isolating from citrus oils such compounds as: S-geranoxypsoralen; 7- methoxy-S-geranoxycoumarins; -(gamma,gamma dimethyl) allyloxypsoralen; 7-methoxy-5-(gamma,gammadimethyl) allyloxycoumarin; 8-geranoxypsoralen; 5,7-dimethoxycoumarin; and 5-rnethoxy-8-(2,3-dihydroxy-3- methylbutoxy)-psoralen. Another object of the invention is the provision of the hitherto-unknown compound, S-geranoxypsoralen, in pure crystalline form free from other citrus oil components. Another object of the invention is the provision of methods for converting the naturally occurring coumarins and furocoumarins into other derivatives, for example, conversion of S-geranoxypsoralen into S-methoxypsoralen. Further objects and advantages of the invention will be obvious from the following description.
It has recently been shown that certain derivatives of psoralen, particularly 8-methoxypsoralen, possms what is termed photodynamic activity in that the compounds when applied locally, or even taken internally, enhance tanning of the skin when the subject is exposed to sunlight or other radiation containing ultra-violet rays. The compounds thus serve as protective agents in that the skin becomes tanned instead of developing soreness, blisters, etc.
At present the only commercial source for 8-methoxypsoralen is the seed of Ammi majus, a plant grown in Egypt. Some of the furocoumarins (S-geranoxypsoralen, for instance) have been shown to be present in bergamot or other citrus fruits but known methods for recovering these compounds are not efiicient and generally result in loss by decomposition of one or more of the active components.
It has now been found that the compound S-geranoxy psoralen is present in citrus oils, particularly lemon and lime oils. This compound can be isolated from the oil by a process which involves primarily adsorption on an adsorbent material followed by elution with a suitable solvent. It has also been found that by this same isolation method, other coumarins and furocoumarins can be recovered. The isolated 8-geranoxy-psoralen can be converted into 8-methoxypsoralen or other alkyl ethers as described below. Similar syntheses can be applied to the other compounds isolated from the citrus oil. It is to be emphasized that the presence of 8-geranoxypsoralen in citrus products was not known prior hereto.
Referring now in particular to the method of extracting the citrus oil, the following procedure is used: The raw atent ice material for this purpose is usually an oil obtained by cold pressing the peels of lemons, limes, grapefruit, bitter oranges, bergamot, etc. Citrus oils obtained by other procedures which do not involve distillation can also be used. Where the citrus oil is purified by distillation, the distillation residue (undistilled material) contains the desired compounds and can be used as the starting material. In any event, the oil is first adsorbed on a finely divided adsorbent material such as silicic acid. This material containing adsorbed oil is then eluted with a terepenophilic solvent such as hexane whereby the undesired terpene hydrocarbons originally present in the oil are selectively eluted from the adsorbent. The adsorbent is then eluted with a liquid containing both a terpenophilic solvent, such as hexane, and an oxygenated organic solvent, such as ethyl acetate. The eluate which contains the various ethereal components of the oil iscollected in separate fractions as it flows out of the adsorbent column. These fractions are subjected to analytical tests and those which are rich in a particular component are combined. The combined material is then subjected to evaporation to remove at least part of the eluting solvent and the coumarin or furocoumarin is crystallized from the concentrated eluate.
The extraction and purification process is further demonstrated by the following illustrative examples:
EXAMPLE I A. Preparation of adsorbent column Powdered silicic acid was formed into a slurry with hexane and poured into a conventional chromatographic cylinder. Nitrogen gas under pressure was applied at the top of the column to force out excess hexane. There was formed a column of hexane-wetted silicic acid 3.5 inches in diameter and 10 inches long.
B. Adsorption of oil on column Three hundred grams of whole, cold-pressed lemon oil was poured on top of the column and forced, by application of nitrogen gas under pressure at the top of the column, into the adsorbent column.
C. Removal of terpenes Hexane (1,100 ml.) 'was run through the column containing the adsorbed lemon oil until essentially all the undesired terpene hydrocarbons had been washed out as an eifiuent containing the terpenes dissolved in hexane.
D. Elution of coumarins dnd furocoumarins The column was then eluted with 22,500 ml. of a solution of ethyl acetate in hexane, starting with 1% ethyl acetate in hexane and increasing the proportion of ethyl acetate in each batch of about 1,000 ml. until the final concentration of ethyl acetate was The column was then eluted with 500 ml. of pure ethyl acetate and finally with 1,000 ml. of 10% ethyl alcohol in ethyl acetate. The eluate leaving the bottom of the column was collected in fractions, each containing about 25 ml., by using an automatic fraction collector. The total volume of solvent used for the elution was 24,000; 1,037 individual fractions 'were taken.
E. Identification of fractions and isolation of products The eluate fractions were subjected to tests to determine which of them contained the same compounds. For these tests, a spot of eluate was placed on a micro-column, that is, a glass strip coated with silicic acid containing starch as a binder. The adsorbent mixture also contained a minor proportion of zinc cadmium sulphide and zinc silicate as a phosphor. The strips were then subjected to ascending development with a solvent consisting of 25% ethyl acetate in hexane. The individual compounds could then be identified by the degree of migration of the spot (R value) and by the color of the spot when exposed to ultra violet light. As well known in the art, the R value is the ratio of the distance through which the spot migrates to the distance advanced by the solvent itself (solvent front). The particular values of R and color under ultra violet light for the various components of the eluate are set forth below.
(1) The first portion of the eluate contained the known compound S-geranoxy psoralen where R represents the geranyl radical:
CH3 (3H3 OHZ OH= CHTCHQCH=C CHQ This compound, also known as bergamottin, in the described chromatographic test, gave an R; value of 0.68 and a purple color under ultra-violet light.
Fractions Nos. 261 to 305 of the eluate which contained this compound were combined. This composite was evaporated to a volume of about 5 ml. under vacuum in a flow of nitrogen gas. The resulting solution was allowed to stand overnight in a refrigerator whereby it deposited crystals. The crystals were removed and washed with petroleum ether. The crystals of 5-geranoxypsoralen had a melting point of 57.5 to 58.5 C. and were obtained in a yield of 280 mg. The compound was identified as S-geranoxypsoralen by elemental analysis of it, the corresponding phenol, and corresponding acetate.
(2) The second portions of the eluate contained the known compound 7-methoxy-S-geranoxycoumarin:
10 11 This compound in the described test gave an R value of 0.64 and the spot fiuoresced bright blue under ultra-violet light.
Fractions Nos. 315 to 350 of the eluate which contained this compound were combined. This composite was evaporated to a volume of about 6 ml. under vacuum in a flow of nitrogen gas. The resulting solution was allowed to stand overnight in a refrigerator. The crystals which formed were separated. The product was identified as 7-methoxy-S-geranoxycoumarin by elemental analysis and by ultraviolet light and infra-red spectra.
(3) The third portion of the eluate contained a compound giving an R; value of 0.57 and a purple color under ultra violet light.
Fractions Nos. 351 to 359 of the eluate which contained this compound were combined. This composite was evaporated to a volume of about 1 ml. under vacuum in a flow of nitrogen gas. The resulting solution was allowed to stand overnight in a refrigerator whereby it deposited crystals. The crystals were removed and found to have a melting point of 94-96" C. It is believed that this compound is -(gamma,gamma-dimethyl) allyloxy psoralen, also known as isoimperatorin:
(4) The fourth portion of the eluate contained a compound giving an R; value of 0.5 and a blue color under ultra-violet light.
4 Fractions Nos. 380 to 405 of the eluate which contained this compound were combined. The composite was evaporated to a volume of about 2 ml. under vacuum in a flow of nitrogen gas. The resulting solution was stored overnight in a refrigerator whereby it deposited crystals. The crystals were separated and found to have a melting point of -92 C. It is believed that this compound is 7-methoXy-5-(gamma,gamma dimethyl) allyloxycoumarin:
(5) The fifth portion of the eluate contained the compound S-geranoxypsoralen:
wherein R represents the geranyl radical.
This compound in the described test gave an R; value of 0.4 and a violet color under ultra violet light.
Fractions Nos. 406 through 475 of the eluate which contained this compound were combined. The composite was concentrated to about 3 ml. by evaporation under vacuum in a flow of nitrogen gas. The resulting solution was allowed to stand overnight at 38 P. whereby it deposited fine crystals. The crystals (178 mg.) were filtered off with suction and washed on the filter with cold petroleum ether. The yield was 0.05% based on the original lemon oil.
The compound S-geranoxypsoralen has a melting point of 59-60" C.; it is insoluble in water, sparingly soluble in petroleum ether, moderately soluble in alcohol and ethyl ether, and quite soluble in ethyl acetate. Its ultra violet spectrum shows maxima at 217, 250, and 298 millimicrons, shoulders at 244 and 264 millimicrons, and minima at 232 and 277 millimicrons.
The crystalline compound was identified as 8-geranoxypsoralen based on the following observations: The compound gave a carbon and hydrogen analysis correct for C H O The compound exhibited typical lactone behavior and absence of free phenol hydroxyl groups by virtue of the effect of cold caustic (no shift in spectral peaks) and heating with caustic (marked shift of spectral peaks toward red) on its ultra violet spectra. Cleavage with weak acids indicated the presence of an allylic type ether group which Was confirmed to be the geranyl other group by infra red spectral studies. Also the compound when cleaved with weak acid formed a phenol which on methylation or acetylation formed the known compounds S-methoxypsoralen, and 8-acetoxypsoralen, respectively.
(6) The sixth portion of the eluate contained the known compound 5,7-dimethoxy coumarin, also known as limettin.
This compound in the described test gave an R, value of 0.25 and a blue color under ultra-violet light.
Fractions Nos. 500 to 605 of the eluate which contain this fraction were combined. The composite was evaporated to a volume of about 6 ml. under vacuum in a. flow of nitrogen gas. The resulting solution was stored overnight in a refrigerator. The separated crystals were removed and found to have a melting point of l47- 148 C.
OH OH O-CHz-CH-C-CHa This compound in the described test gave an R value of zero and a lavender color when exposed to ultraviolet light.
Fractions Nos. 937 to 1037 of the eluate containing this compound were combined. The composite was evaporated to a volume of about 3 ml. under vacuum in a flow of nitrogen gas. The resulting solution was stored overnight in a refrigerator. The separated crystals were removed and found to have an ultra violet curve identical with that of an authentic sample of byakangelicin.
In the table below are set forth the yields of the seven compounds referred to above. The data represent the average of seven runs carried out as described above.
Com- Yield, mg.
Name per 200 g. pound lemon oil fi-geranoxypsoralen 197 7-meth0xy-5-geranoxy-coumar1n- 189 -(gamrua,gamma-dimethyl) allyloxy-psoralen. 8
7-methoxy-5(gamma,gamma-d1methyl) allyloxycoumarin 9 8-geranoxypsoralen 96 5,7-dimethoxycoumarin 139 By ksm elicin 130 EXAMPLE II Another run was carried out as described in Example 1, parts A to D. In this instance 200 g. of cold-pressed lemon oil was adsorbed on a column of silicic acid 2.5 inches in diameter and 11 inches long. The terpenes were removed by eluting the column with 400 ml. of hexane. The column was then eluted with 15,500 ml. of a solution of ethyl acetate in hexane, starting with 0.5% ethyl acetate in hexane and increasing the proportion of ethyl acetate in each batch of about 1,000 ml. until the final concentration of ethyl acetate was 90% The column was then eluted with 500 ml. 5% ethyl alcohol in ethyl acetate and finally with 500 ml. 25% ethyl alcohol in ethyl acetate. A total of 835 eluate fractions were collected. Fractions 425-475 were combined and the solution evaporated and 136 mg. of crystals of 8-geranoxypsoralen were obtained. The yield was 0.07% by weight based on the lemon oil.
EXAMPLE III Another run was carried out as described in Example 1, parts A to D. In this instance, 190 g. of lime oil was adsorbed on a column of silicic acid 2.5 inches in diameter and 11 inches long. The terpenes were removed by eluting the column with 1,000 ml. hexane. The column was then eluted with 7,000 ml. of a solution of ethyl acetate in hexane, starting with a solution containing 5% ethyl acetate in hexane and increasing the proportion of ethyl acetate in each batch of about 500 ml. until the final concentration of ethyl acetate was 75%. The column was then eluted with 400 ml. of 5% ethyl alcohol in ethyl acetate and finally with 500 ml. of ethyl alcohol in ethyl acetate. A total of 965 fractions were collected.
'A number of these fractions which contained S-geranoxy psoralen were combined and this compound recovered therefrom by evaporation and crystallization. The fractions used and the yields of the S-geranoxy compound are listed below:
Amount of a 4 Total 289.9
The total yield of 8-geranoxypsoralen was 0.16% by weight based on the amount of lime oil. 7
In carrying out our process in practice we usually prefer to conduct the adsorption and elutions on a column. To this end a cylinder is packed with a finely divided solid adsorbent. Although we prefer to use silicic acid, various other adsorbents can be employed as for example, alumina, silica, magnesium oxide, magnesium hyf' droxide, aluminum hydroxide, bentonite, clays, diatomaceous earths, and so forth. Preferably this column is first wetted with the terpenophilic solvent whereby to minimize isomerization of reactive compounds present in the citrus oil. The expression terpenophilic solvent as used herein means an organic solvent which has a greater afiinity for terpenes than the latter have afiinity for the adsorbent. As the terpenophilic solvent, we prefer to use hexane although many other materials within this class give good results, examples being benzene, carbon disulphide, carbon tetrachloride, and mixtures of hydrocarbons such as gasoline, petroleum naphtha, petroleum ether, and so forth. Preferably the terpenophilic solvent should have a boiling point below C. to facilitate its removal by distillation from the separated terpenes.
After the column is formed, the citrus oil is applied thereto. By application of vacuum to the receiver"at-' tached to the bottom of the column the oil can be drawn into the adsorbent. If desired, pressure can be applied at the top of the column to force the oil into the adsorbent. The column is then ready for elution of the terpene constituents. This is accomplished by washing the column with hexane or other terpenophilic solvent as described above. In conducting this elution, it is preferable to pass the selected solvent through the adsorbent column while taking small samples of the efiluent liquidand subjecting them to chromatographic or other analytical tests. By this means, one can ascertain when the effluent contains the terpenes. The terpene-containing efiluent can then be collected and saved for recovery of terpenes. By continuing the tests, the point when the eflluent no longer contains terpenes can also be determined. At this point the collection of the solvent can be discontinued and the column is ready for elution of the coumarin and furocoumarin derivatives. The total amount of terpenophilic solvent to be used will vary depending on the amount of adsorbent and amount of terpenes in the citrus oil. In any case by using the tests on the efiluent liquor, the
proper amount of solvent to use can be determined for each particular case.
The terpenes may be recovered from the efiiuent solution by distillation. Vacuum distillation is preferred to minimize decomposition of the terpenes.
After the terpenes have been washed out of the column, the column is eluted to remove the coumarins and furocoumarins. This elution is conducted with ethyl acetate or other oxygenated organic solvent such as diethyl ether, dioxane, acetone, ethyl alcohol, normal or iso-propyl alcohol, any of the isomeric butyl alcohols, etc. Preferably the elution is initially conducted with a solvent which contains both oxygenated organic solvent and terpenophilic solvent, for example, a solution of ethyl acetate in hexane. In this way the various oxygenated compounds adsorbed on the column are eluted more or less serially rather than in one batch containing all of them.
Usually it is preferred to increase the proportion of oxygenated organic solvent in proportion to the terpenophilic solvent to enhance this serial-wise elution effect. In the last stages of the elution, the solvent contains only the oxygenated organic solvent, for example, ethyl acetate, ethyl alcohol, or mixtures thereof.
As the eluate flows from the column, it is collected in separate fractions, for example, by the use of an automatic fraction collector as is well known in the field of chromatography. These individual fractions are then subjected to chromatographic or other tests to ascertain the presence of the desired furocoumarin. The fractions which contain this compound are then combined, subjected to evaporation to remove at least part of the solvent and allowed to stand, preferably with cooling, to allow the compound to crystallize out. The other fractions may be likewise treated to isolate the various coumarins or furocoumarins originally present in the citrus oil. The eluate fractions which contain two or more of the desired components can be re-treated to separate them. To this end the fractions are subjected to evaporation to remove solvent and the residue is adsorbed on a solid adsorbent material and eluted as previously described.
In the preferred modification of the invention, terpenes are removed from the citrus oil by elution of the adsorbed oil with hexane or similar terpenophilic solvent. Other methods can be used to eliminate the terpenes, for example, application of distillation to remove the terpenes as a vapor and leave behind the essentially nonvolatile coumarins and furocoumarins. The distillation residue can then be processed as described to separate the individual components.
As briefly noted above, S-geranoxypsoralen can be readily converted into derivatives having photodynamic activity. Such synthesis is preferably accomplished in two stagesfirst by splitting the 8-geranoxypsoralen to form 8-hydroxypsoralen and then reacting the latter with an etherification agent. In the first stage the S-geranoxy compound is reacted with an ether hydrolyzing agent, for example, acetic acid, sulphuric acid, hydrochloric acid, hydroiodic acid or the like. Usually the hydrolysis is performed with glacial acetic acid which acts both as a solvent and as a hydrol ytic agent. To expedite hydrolysis a minor amount of strong acid such as sulphuric is added. to the reaction mixture. In general, the hydrolysis can be conducted at a temperature from about zero to 100 C. depending on the eflicacy of the hydrolysis agent selected. Where the hydrolysis is conducted with the S-geranoxy compound dissolved in an inert solvent such as ethanol, benzene, acetone, etc, and the reaction is carried out at a temperature above the boiling point of the solvent, refluxing conditions may be employed to prevent loss of solvent. In the second stage of the synthesis the 8-hydroxypsoralen is reacted with an etherifying agent, for example diazomethane, dimethyl sulphate, or methyl iodide where the aim is to prepare the 8-methoxy derivative. In the event that different ethers are desired, one may use such etherification agents as for example diethyl sulphate, ethyl iodide, dipropyl sulphate, propyl iodide, diisopropyl sulphate, isopropyl iodide, di-butyl sulphate, butyl iodide, and so forth. Where the etherificattion is conducted with an alkyl sulphate or halide, an alkaline agent such as potassium carbonate, sodium carbonate, potassium hydroxide, sodium hydroxide, lime, sodium ethylate, or the like is added to the reaction mixture to promote the etherification by reacting with the anion of the etherifying agent. The etherification is preferably conducted under reflux in the presence of an inert solvent such as acetone, ethanol, dioxane, etc.
Instead of using the two-stage procedure outlined above, .a single stage, trans-etherification may be employed. To this end the 8 -geranoxy derivative may be refluxed with an excess of absolute methanol in the presenceof an acid catalyst such as hydrogen chloride, sulphuric acid, etcJto obtain a replacement of the geranyl radical with the methyl radical. Similar syntheses with propyl alcohol, isopropyl alcohol or any of the isomeric butyl alcohols can be accomplished in the same general manner.
The procedures described above for the conversion of S-geranoxy psoralen to 8-methoxypsoralen (or other 8-alkoxysporalen) can be also applied to the other derivatives isolated from citrus oil. Thus by these procedures, for example, the geranoxy or the gamma,gamma dimethyl allyloxy side chains can be converted into methoxy or other alkoxy groups. Typical examples of such syntheses are the conversion of S-geranoxypsoralen to S-methoxypsoralen; the conversion of 7-methoxy-5-geranoxy coumarin to 5,7-dirnethoxy coumarin; the conversion of 5-(gamma,gamma-dimethy1) allyloxypsoralen to 5- methoxypsoralen; the conversion of S-(gamma-gamma, dimethyl)-allyloxycoumarin to S-methoxycoumarin; and so forth.
The conversion of 8-geranoxypsoralen to S-methoxypsoralen is further demonstrated by the following illustrative examples.
EXAMPLE IV A. Cleavage of 8-geranoxyps0ralen Two hundred seventy-five mg. of 8-geranoxypsoralen was dissolved with mechanical stirring in 4 ml. glacial acetic acid. After 10 minutes, one drop of concentrated sulphuric acid was added to the solution. In 4 minutes thereafter a light tan precipitate began to form. Stirring B. Methylation of 8-hydr0xypsoralen One hundred fifteen mg. of 8-hydroxypsoralen was dissolved in 10 ml. absolute methanol, an excess of diazomethane dissolved in ether was added and the mixture allowed to stand at room temperature with occasional stirring for 3 hours. The next day the reaction mixture was reduced in volume to 3 ml. by evaporation on the steam bath and the concentrate was held in a refrigerator overnight. The next day, fine needles mg.) of S-methoxypsoralen were filtered from the solution. The compound had a melting point of l45l46 C. and was obtained in a yield of 65% of theory. The product was compared with an authentic sample of S-methoxypsoralen by mixed melting point, ultra-violet, and infra-red spectra and the two were found to be identical.
EXAMPLE V Methylation of 8-hydr0xypsoralen with methyl iodide (or sulphate) EXAMPLE VI A. Clevage of S-germzoxypsoralen Four hundred and ninety milligrams of S-geranoxypsoralen was dissolved in 5 cc. glacial acetic acid. One
.drop of concentrated sulphuric acid was added and the reaction mixture stirred for 2 hours. A tan colored precipitate formed which was filtered oii. A -yield B. Methylation of S-hydroxypsoralen Forty mg. of S-hydroxypsoralen, 20 ml. of anhydrous acetone, 0.2 g. of potassium carbonate and 1 m1. of dimethyl sulphate were refluxed for 3 hours. The reaction mixture was allowed to cool and 50 ml. of water added. Fine needles formed which were filtered off and recrystallized from alcohol. A yield of 14 mg. of S-methoxypsoralen was obtained.
Having thus described the invention, what is claimed is:
1. A process for isolating coumarins and furocoumarins from a citrus oil which comprises adsorbing the citrus oil on a solid adsorbent material, eluting the adsorbent material with a liquid comprising an oxygenated organic solvent, collecting the resulting eluate in a series of fractions containing individual coumarins and furocoumarins, and individually recovering the coumarins and furocoumarins from the fractions.
2. A process for isolating a furocouman'n from a citrus oil which comprises adsorbing the citrus oil on a solid adsorbent material, eluting the adsorbing material with a liquid comprising an oxygenated organic solvent, collecting the resulting eluate in a series of fractions, separating the fractions containing the furocoumarin, and recovering the furocoumarin therefrom.
3. The process of claim 2 wherein the furocoumarin is S-geranoxypsoralen.
4. The process of claim 2 wherein the furocoumarin is S-geranoxypsoralen.
5. The process of claim 2 wherein the furocoumarin is 5-(gamma,gamma-dimethyl) allyloxypsoraleu.
6. The process of claim 2 wherein the furocoumarin is 5-methoxy-8(2,3-dihydroxy-3-methylbutoxy)psoralen.
7. A process for isolating furocoumarins from a citrus oil which comprises adsorbing a citrus oil on a solid adsorbent material, extracting the adsorbent material with a terpenophilic solvent to remove terpene constituents, eluting the adsorbent material with a liquid comprising a terpenophilic solvent and an oxygenated organic solvent then with an oxygenated solvent alone, collecting the resulting eluate in a series of fractions containing individual furocoumarins, and individually recovering furocoumarins from the fractions.
8. The process of claim 7 wherein the turocoumarins include S-geranoxypsoralen.
9. The process of claim 7 wherein the furocoumarins include S-geranoxypsoralen.
10. The process of claim 7 wherein the furocoumarins include 5-(=gamma,gamma-dimethyl)-allyloxypsoralen.
11. The process of claim 7 wherein the furocoumarins include S-methoxy-S(2,3-dihydroxy-3-methyl butoxy)- psoralen.
12. A process for isolating S-geranoxypsoralen from citrus oil which comprises adsorbing the citrus oil on a solid adsorbent, extracting the adsorbent with hexane to remove terpene components, eluting the adsorbent with initially a liquid containing a minor proportion of ethyl acetate dissolved in hexane, then with a series of liquids containing increasing proportions of ethyl acetate to hexane, then with ethyl acetate alone, and finally with a liqud containing ethyl acetate and ethanol, collecting the eluate in a series of separate fractions, combining the fractions which contain S-geranoxypsoralen and recover- :ing the S-geranoxypsoralen therefrom.
13. A process for isolating S-geranoxypsoralen from citrus oil which comprises adsorbing the citrus oil on a :solid adsorbent, extracting the adsonbent with hexane to remove terpene components, eluting the adsorbent with initially a liquid containing a minor proportion of ethyl acetate dissolved in hexane, then with a series of liquids containing increasing proportions of ethyl acetate to l hexane, then with ethyl acetate alone, and finally with a liquid containing ethyl acetate and ethanol, collecting the eluate in a series of separate fractions, combining the fractions which contain 8-geranoxypsoralen and recovering the 8-geranoxypsoralen therefrom.
References Cited in the file of this patent Bennet et al.: Chem. Abst., vol. 47, p. 3937i (1953).
Noguchi: Chem. Abst., vol. 44, p. 3989 (1950).
Spath et al.: Chem. Abst., vol. 32, p. 550 (1938).
Kirchner: Ind. Eng. Chem, vol. 44, pp. 318-21 (1952).
Sethna et al.: Chem. Reviews, vol. 36, No. 1, pp. -51 (February 1945).
Cassidy, Adsorption and Chromatography, Technique of Organic Chemistry, vol. 5, pp. -157, Interscience 1951).
Shriner et al.: Identification of Organic Compounds, third edition, p. 187, Wiley and Sons (1948).

Claims (1)

1. A PROCESS FOR ISOLATING, COUMARINS AND FUROCOUMARINS FROM A CITRUS OIL WHICH COMPRISES ADSORBING THE CITRUS OIL ON A SOLID ADSORBENT MATERIAL, ELUTING THE ADSORBENT MATERIAL WITH A LIQUID COMPRISING AN OXYGENATED ORGNAIC SOLVENT, COLLECTING THE RESUDLTING IN A SERIES OF FRACTIONS CONTAINING INDIVIDUAL COUMARINS AND FUROCOUMARINS, AND INDIVIDUALLY RECOVERING THE COUMARINS AND FUROCOUMARINS FROM THE FRACTIONS.
US598971A 1956-07-19 1956-07-19 Isolation of furocoumarins Expired - Lifetime US2889337A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US598971A US2889337A (en) 1956-07-19 1956-07-19 Isolation of furocoumarins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US598971A US2889337A (en) 1956-07-19 1956-07-19 Isolation of furocoumarins

Publications (1)

Publication Number Publication Date
US2889337A true US2889337A (en) 1959-06-02

Family

ID=24397675

Family Applications (1)

Application Number Title Priority Date Filing Date
US598971A Expired - Lifetime US2889337A (en) 1956-07-19 1956-07-19 Isolation of furocoumarins

Country Status (1)

Country Link
US (1) US2889337A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130568A (en) * 1976-09-14 1978-12-19 Hoffmann-La Roche Inc. 8-Methoxypsoralen derivatives
US4169840A (en) * 1977-10-03 1979-10-02 Oy Star Ab Method of preparing furocoumarins
US4217445A (en) * 1976-05-28 1980-08-12 Fotobio Holding Ag 5-Oxy-substituted derivatives of Psoralene useful in dermatology

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217445A (en) * 1976-05-28 1980-08-12 Fotobio Holding Ag 5-Oxy-substituted derivatives of Psoralene useful in dermatology
US4130568A (en) * 1976-09-14 1978-12-19 Hoffmann-La Roche Inc. 8-Methoxypsoralen derivatives
US4169840A (en) * 1977-10-03 1979-10-02 Oy Star Ab Method of preparing furocoumarins

Similar Documents

Publication Publication Date Title
Steele et al. The solvolysis of stigmasteryl tosylate
Fieser Synthesis of vitamin K1
Fox et al. Hydrolysis of some flavonoid rhamnoglucosides to flavonoid glucosides
Rowland Flue-cured tobacco. III. Solanachromene and α-tocopherol
US4708820A (en) Method of producing phenol-type natural antioxidative materials from processed sesame seed products
US4013731A (en) Process for the manufacture of solanesol
Wells et al. A preparative method for the isolation of brain cerebroside, sulfatide and sphingomyelin
US2889337A (en) Isolation of furocoumarins
US2819298A (en) Process for the manufacture of carotenoids
US2934570A (en) Intermediates for synthesis of arachidonic acid
JPH0692383B2 (en) Tocopherol purification method
US2920103A (en) 11-monocis isomer of vitamin a
US2540118A (en) Process for the manufacture of pentaenes
Angyal et al. 267. Cyclitols. Part IV. Methyl ethers of myo inositol
US3549668A (en) Process for the manufacture of coenzymes q9,q10,q11 and q12 and novel coenzymes q11 and q12
Bobbitt et al. Catalpa Glycosides. III. 1, 2 The Structure of Catalposide
Termont et al. Regio-and stereo-selectivity in [π 2+ π 2] photocycloaddition reactions between cyclopent-2-enone and electron-rich alkenes
US2451735A (en) Polyenes and process for the manufacture thereof
WO2019218087A1 (en) Conversion of hydrocannabinols to cannabinol
US3526669A (en) Process for the manufacture of isoprenyl alcohols having 9,11,and 12 isoprene units and new isoprenyl alcohols
CN113354526B (en) Alkali purification method of coenzyme Q10
Angyal et al. The preparation of cyclohexanepentols from inositols by deoxygenation
US2451738A (en) Process for the manufacture of pentaenes
US2228491A (en) Dihydrotachysterol
Lespieau Synthesis of hexitols and pentitols from unsaturated polyhydric alcohols